Implanet SA (ALIMP) - Total Liabilities
Based on the latest financial reports, Implanet SA (ALIMP) has total liabilities worth €18.04 Million EUR (≈ $21.09 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Implanet SA long-term investment intensity to see how much of total assets are deployed in long-term investments.
Implanet SA - Total Liabilities Trend (2010–2025)
This chart illustrates how Implanet SA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Implanet SA balance sheet assets.
Implanet SA Competitors by Total Liabilities
The table below lists competitors of Implanet SA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Korea Eng Cons
KO:023350
|
Korea | ₩270.72 Billion |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
Thailand | ฿259.55 Million |
|
Megachem (Thailand) Public Company Limited
BK:MGT
|
Thailand | ฿330.14 Million |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
USA | $5.64 Million |
|
IFS Capital (Thailand) Public Company Limited
BK:IFS
|
Thailand | ฿2.35 Billion |
|
Arvee Laboratories (India) Limited
NSE:ARVEE
|
India | Rs91.40 Million |
|
Borealis Foods Inc.
NASDAQ:BRLS
|
USA | $69.25 Million |
|
Impero AS
CO:IMPERO
|
Denmark | Dkr22.57 Million |
Liability Composition Analysis (2010–2025)
This chart breaks down Implanet SA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See debt-free asset ratio of Implanet SA to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 44.66 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.98 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Implanet SA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Implanet SA (2010–2025)
The table below shows the annual total liabilities of Implanet SA from 2010 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €18.04 Million ≈ $21.09 Million |
+27.40% |
| 2024-12-31 | €14.16 Million ≈ $16.56 Million |
+31.01% |
| 2023-12-31 | €10.81 Million ≈ $12.64 Million |
-1.12% |
| 2022-12-31 | €10.93 Million ≈ $12.78 Million |
-21.34% |
| 2021-12-31 | €13.90 Million ≈ $16.25 Million |
+80.99% |
| 2020-12-31 | €7.68 Million ≈ $8.98 Million |
-6.50% |
| 2019-12-31 | €8.21 Million ≈ $9.60 Million |
+27.41% |
| 2018-12-31 | €6.45 Million ≈ $7.54 Million |
+2.74% |
| 2017-12-31 | €6.28 Million ≈ $7.34 Million |
-7.69% |
| 2016-12-31 | €6.80 Million ≈ $7.95 Million |
+3.56% |
| 2015-12-31 | €6.56 Million ≈ $7.67 Million |
-10.57% |
| 2014-12-31 | €7.34 Million ≈ $8.58 Million |
-27.00% |
| 2013-12-31 | €10.06 Million ≈ $11.76 Million |
+41.78% |
| 2012-12-31 | €7.09 Million ≈ $8.29 Million |
-9.73% |
| 2011-12-31 | €7.86 Million ≈ $9.19 Million |
+62.44% |
| 2010-12-31 | €4.84 Million ≈ $5.65 Million |
-- |
About Implanet SA
Implanet S.A., together with its subsidiaries, manufactures and sells implants and medical instruments for orthopedic surgery in France, the United States, Europe, the Middle East, Africa, and internationally. The company offers spinal and knee products, including Jazz PF, Jazz Evo, Jazz Cap SP, Jazz Passer, Jazz Lock, Jazz Claw, Olea, Saxxo, Swingo, Shark, Origin, and Jazz Frame, as well as ISS-… Read more